Advanced Solid Tumors Clinical Trials
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
M
Recruiting
- Advanced Solid Tumors
- MK-1084
- Pembrolizumab
- Liverpool, New South Wales, Australia
- +15 more
2022-04-07
Apr 7, 2022A
Recruiting
- Advanced Solid Tumors
- AMG 994
- AMG 404
- Duarte, California
- +16 more
2022-04-06
Apr 6, 2022G
Recruiting
- Advanced Solid Tumors
- Grand Rapids, Michigan
- +2 more
2022-04-07
Apr 7, 2022N
Recruiting
- HRD Cancer
- +2 more
- Berzosertib
- Sacituzumab Govitecan
- Bethesda, MarylandNational Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022N
Recruiting
- Advanced Solid Tumors
- +5 more
- Fairway, Kansas
- +1 more
2022-04-07
Apr 7, 2022I
Recruiting
- Advanced Solid Tumors
- New Haven, Connecticut
- +20 more
2022-04-06
Apr 6, 2022E
Completed
- Advanced Solid Tumors
- MSC2490484A (M3814)
- +2 more
- Fresno, California
- +25 more
2022-04-06
Apr 6, 2022K
Recruiting
- Advanced Solid Tumors
- KSQ-4279
- KSQ-4279 will be combined in separate cohorts, including combination with an oral PARPi (poly adenosine diphosphate-ribose polymerase inhibitor)
- Boston, Massachusetts
- +4 more
2022-04-05
Apr 5, 2022S
Active, not recruiting
- Advanced Solid Tumors
- +4 more
- Phoenix, Arizona
- +15 more
2022-04-04
Apr 4, 2022S
Recruiting
- Advanced Solid Tumors
- Sarcoma
- Los Angeles, California
- +9 more
2022-04-04
Apr 4, 2022S
Recruiting
- Advanced Solid Tumors
- JS108 (recombinant humanized anti-Trop2 mAb-Tub196 conjugate for injection)
- Beijing, Beijing, China
- +2 more
2022-04-01
Apr 1, 2022S
Completed
- Advanced Solid Tumors
- Houston, Texas
- +2 more
2022-04-04
Apr 4, 2022S
Completed
- Advanced Solid Tumors
- Scottsdale, Arizona
- +4 more
2022-04-04
Apr 4, 2022S
Completed
- Cancer
- Advanced Solid Tumors
- Chicago, Illinois
- +10 more
2022-04-04
Apr 4, 2022J
Recruiting
- Advanced Solid Tumors
- Camrelizumab for Injection, Famitinib malate capsule, Paclitaxel For Injection(Albumin Bound)
- Shanghai, Shanghai, ChinaShanghai Chest Hospital
2022-04-02
Apr 2, 2022A
Active, not recruiting
- Advanced Solid Tumors
- Venetoclax
- +2 more
- La Jolla, California
- +25 more
2022-03-23
Mar 23, 2022S
Recruiting
- Advanced Solid Tumors
- +2 more
- Orange, California
- +5 more
2022-03-31
Mar 31, 2022A
Active, not recruiting
- Advanced Solid Tumors
- paclitaxel
- +3 more
- Scottsdale, Arizona
- +9 more
2022-03-23
Mar 23, 2022A
Recruiting
- Advanced Solid Tumors
- Denver, Colorado
- +5 more
2022-03-21
Mar 21, 2022A
Active, not recruiting
- Advanced Solid Tumors
- Birmingham, Alabama
- +11 more
2022-03-31
Mar 31, 2022A
Recruiting
- Advanced Solid Tumors
- AMG 256
- Duarte, California
- +9 more
2022-03-30
Mar 30, 2022A
Active, not recruiting
- Advanced Solid Tumors
- Scottsdale, Arizona
- +53 more
2022-03-31
Mar 31, 2022A
Active, not recruiting
- Advanced Solid Tumors
- ALKS 4230
- ALKS 4230 + pembrolizumab
- Denver, Colorado
- +30 more
2022-03-29
Mar 29, 2022A
Active, not recruiting
- Advanced Solid Tumors
- ASP1948
- +2 more
- New Haven, Connecticut
- +48 more
2022-03-30
Mar 30, 2022D
Recruiting
- Advanced Solid Tumors
- Debio 0123
- Grand Rapids, Michigan
- +3 more
2022-03-30
Mar 30, 2022